Industry: Pharmaceuticals (See others in industry)
Address:| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2024-04-22 | Amended | $13,400,781 | $8,350,869 | Equity Only | 06b | SEC link |
| 2023-04-07 | New | $5,049,912 | $5,049,912 | Equity Only | 06b | SEC link |
| Name | Role |
|---|---|
| George Alex | Director, Executive |
| Thierry Porte | Director |
| Rudolph Tanzi | Director |